Brazil Export Data for Other Retail Alkaloid Medicaments Under HS Code 30044990
HS Code 30044990 is officially defined as Medicamentos (exceto os produtos das posições 30.02 30.05 ou 30.06) constituídos por produtos misturados ou não misturados preparados para fins terapêuticos ou profiláticos apresentados em doses (incluindo os destinados a serem administrados por via percutânea) ou acondicionados para venda a retalho: Outros que contenham alcaloides ou seus derivados: Outros in Brazil. Brazil classifies these goods under the Nomenclatura Común del Mercosur (NCM), which extends the 6-digit HS to 8 digits. Explore Brazil export shipment records for Other Retail Alkaloid Medicaments classified under HS Code 30044990.
Latest Brazil Export Trade Records For Other Retail Alkaloid Medicaments Under HS Code 30044990
As of 2026-07-20, companies recorded in Brazil export shipments of Other Retail Alkaloid Medicaments (HS Code 30044990) include Sun Farmaceutica Do Brasil Ltda, as declared on bill of lading trade records. These shipments are destined for INDIA. In 2025, Brazil's total export value for the parent 6-digit category 300449 was US$ 804,130. Full shipment records include fields such as exporter, importer, country of origin, destination country, trade value, weight, quantity, and ports of loading and discharge.
Subscribe Now to run unlimited searches and unlock full shipment records, trade partners and trade metrics for Other Retail Alkaloid Medicaments under HS Code 30044990.
1-10 of 8,200M+ Bill of Lading database covers import export Trade records updated till 2026-07-20
Access Full & Detailed Trade Data for HS Code 30044990
Reveal full shipment records, buyers, suppliers and trade metrics for Other Retail Alkaloid Medicaments, and run unlimited searches across TradeInt global trade database.
Top Export Products Related to HS Code 30044990 (Other Retail Alkaloid Medicaments) in Brazil
Based on Brazil export trade data, top export products related to HS Code 30044990 in Brazil are:
Aggregated Brazil export data for 2025.